Bedside diaphragm ultrasound to measure breathing-muscle movement during COPD flare-ups
Official title: Ultrasound of the Diaphragm Excursion Ratio as Physiological Biomarker in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Run by Isala · NCT07259174 · Data updated 2026-11-12
This project tests whether a quick bedside ultrasound measurement of diaphragm movement can help doctors understand breathing problems in people hospitalized with severe COPD flare-ups.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 186 (estimated) |
| Sponsor | Isala Academic / other |
| Locations | 2 sites (Zwolle, Overijssel and 1 other locations) |
| Status | Recruiting |
| Started | October 14, 2025 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | December 2, 2025 |
| Trial ID | NCT07259174 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People hospitalized primarily for severe AECOPD with prior spirometry showing FEV1/FVC < 0.70 and FEV1 < 80% predicted, at least 10 pack-years, and the ability to give informed consent and cooperate with ultrasound imaging.
✕Probably not a fit
Patients already on invasive mechanical ventilation, with known diaphragm paralysis, who cannot follow vocal instructions, or who cannot give informed consent (including pregnant women excluded from participation) are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will use bedside ultrasound to measure the diaphragm excursion ratio in patients hospitalized for severe acute exacerbations of COPD. Eligible patients must have prior spirometry confirming COPD (post-bronchodilator FEV1/FVC < 0.70 and FEV1 < 80% predicted) and at least 10 pack-years of smoking; patients who are mechanically ventilated, have known diaphragm paralysis, are pregnant, or cannot cooperate will be excluded. Ultrasound measurements will be collected during hospitalization and compared with clinical data such as blood gases, respiratory support needs (including noninvasive ventilation), and short-term outcomes. The study is conducted at Isala (Zwolle) and University Medical Center Groningen (Groningen) in the Netherlands.
Why it matters
Potential benefit: If successful, this could provide clinicians a quick, noninvasive test to identify patients at higher risk of respiratory failure and help guide decisions about respiratory support.
How similar studies have gone: Previous smaller studies have shown diaphragm ultrasound can reflect respiratory muscle function and sometimes predict outcomes in acute respiratory failure, but using the diaphragm excursion ratio specifically as a biomarker in AECOPD remains relatively untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
• Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Hospitalization primarily because of severe acute exacerbation of COPD * Spirometry record within last 5 years, with: post-bronchodilator FEV1/FVC \< 0,70 and FEV1% \< 80%predicted * Minimum of 10 packyears * Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * Established diagnosis of diaphragm diaphragm paralysis. * Inability for diaphragm imaging (e.g. mechanical ventilation, or unable to follow vocal instructions). * Those not able or unwilling to give written informed consent. * Pregnant women
Where it's running
-
Isala
Zwolle, Overijssel, Netherlands Recruiting -
University Medical Centre Groningen
Groningen, Provincie Groningen, Netherlands Recruiting
Study contacts
- Study coordinator: Wytze S de Boer, MD
- Email: w.s.de.boer@isala.nl
- Phone: +31646312031
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
-
Biomarker clues for COPD, IPF, and lung cancer
This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.
-
HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults
This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.